Latin America Male Infertility Market 2023-2030

Latin America Male Infertility Market 2023-2030

MARKET OUTLOOK

Triton Market Research’s report denotes that the male infertility market in Latin America is anticipated to progress with a compound annual growth rate of 5.36% in value during the forecast period 2023-2030. Brazil, Mexico, and Rest of Latin America are evaluated in the region’s market.

Mexico has become a sought-after destination for fertility tourism due to its cost-effective procedures like IVF and egg freezing. Individuals from countries like the United States and the United Kingdom travel to Mexico to undergo IVF therapy.

However, even after accounting for travel and accommodation costs, undergoing a procedure in Mexico is considerably more affordable than a single IVF cycle in the United States, where the typical cost ranges between $15,000 and $20,000. Hence, cost-effective treatment options drive the male infertility market across the nation.

Argentina has also emerged as a renowned destination for fertility tourism. The nation offers IVF-assisted reproduction technology and sperm DNA fragmentation services for male infertility. Similarly, the Colombian Centre for Fertility and Sterility provides cost-effective treatments for male infertility, such as artificial insemination, in-vitro fertilization, intracytoplasmic sperm injection, etc. Thus, these aspects propel the male infertility market on a progressive path.

COMPETITIVE OUTLOOK

Zydus Lifesciences Limited, CinnaGen Co, Sanofi SA, and Laboratory Corporation of America Holdings are notable companies in the male infertility market.